Presentation of an In Silico and In Vitro Exploration into Combining FDA-Approved Therapies for Treatment-Resistant Melanoma

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-A-011-Tuesday
• By: CICALI, Brian (Stockton University, Galloway, United States)
• Co-author(s): Brian Cicali: Natural Sciences and Mathematics, Stockton University, Galloway, United States
  Robert Olsen: Natural Sciences and Mathematics, Stockton University, Galloway, United States
  
• Abstract:

  Backgrounds

  Melanoma is the deadliest form of skin cancer, killing over 10,000 people annually in the United States. Although multiple FDA-approved therapies exist, treatment resistance is a major issue for oncologists.

  Aims

  This project utilizes in silico and in vitro experimentation to explore combination treatments of established melanoma
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login